Craig Lipset Archives - Rethinking Clinical Trials

June 28, 2023: In This Week’s PCT Grand Rounds, What’s Left for Decentralized Clinical Trials?

Posted on June 28, 2023June 26, 2023 by Damon Seils

Headshots of Adrian Hernandez, Pamela Tenaerts, and Craig Lipset In this Friday’s PCT Grand Rounds, Adrian Hernandez, Pamela Tenaerts, and Craig Lipset will present “Decentralized Trials – From Guidance to Reality & What’s Left.”

The Grand Rounds session will be held on Friday, June 30, 2023, at 1:00 pm eastern.

Dr. Hernandez is a professor of medicine and director of the Duke Clinical Research Institute at Duke University; he is a co–principal investigator of the NIH Pragmatic Trials Collaboratory Coordinating Center. Dr. Tenaerts is the chief scientific officer of Medable, a cloud computing platform for decentralized clinical trials. Dr. Lipset is cochair of the Decentralized Trials & Research Alliance.

Join the online meeting.

July 26, 2019: Digital in Trials: Improving Participation and Enabling Novel Endpoints (Craig H. Lipset)

Posted on July 29, 2019January 20, 2022 by Gina Uhlenbrauck

<span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span><span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span><span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span><span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span><span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span><span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span><span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span><span style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" data-mce-type="bookmark" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

Speaker

Craig H. Lipset
Former Head of Clinical Innovation, Pfizer

Topic

Digital in Trials: Improving Participation and Enabling Novel Endpoints

Keywords

Digital tools; Clinical trials; Participant experience; Patient engagement; Clinical Trials Transformation Initiative

Key Points

To improve trial participation, start by understanding the user/consumer; ie, the trial participant and his or her trial experience.
Digital improvements in clinical trials can involve these incremental steps:
- Study planning that is data-driven, crowdsourced, and informed by artificial intelligence
- Patient engagement that implements electronic consent, flexibility in location, digital concierge support, and data ownership
- Study conduct that integrates remote monitoring, digital biomarkers, and electronically sourced data
- Analysis and reporting that is automated and includes dissemination to trial participants

Discussion Themes

Will digital tools in medicine development enable improvement, disruption, or displacement?

Digital tools in development focus on breaking down barriers to participation, using digital to improve existing measurement or enable new endpoints, and automating processes and tasks while improving quality.

Tags

#pctGR, @Collaboratory1